Take Ltd is Rated Strong Sell

32 minutes ago
share
Share Via
Take Ltd is rated Strong Sell by MarketsMojo, with this rating last updated on 02 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Take Ltd is Rated Strong Sell

Current Rating and Its Significance

MarketsMOJO’s Strong Sell rating for Take Ltd indicates a cautious stance for investors, signalling that the stock currently exhibits multiple risk factors that outweigh potential rewards. This rating is derived from a comprehensive assessment of four key parameters: Quality, Valuation, Financial Trend, and Technicals. While the rating was assigned on 02 July 2026, it is essential to understand the stock’s present-day fundamentals and market behaviour to make informed investment decisions.

Quality Assessment: Below Average Fundamentals

As of 12 September 2026, Take Ltd’s quality grade remains below average, reflecting ongoing operational challenges. The company continues to report operating losses, which undermine its long-term fundamental strength. Its ability to service debt is notably weak, with an average EBIT to interest ratio of -3.06, indicating that earnings before interest and taxes are insufficient to cover interest expenses. This financial strain raises concerns about the company’s sustainability without significant operational improvements.

Furthermore, the return on equity (ROE) stands at a modest 3.35%, signalling low profitability relative to shareholders’ funds. This level of ROE suggests that the company is generating limited value for its investors, which is a critical consideration for those seeking stable and growing returns.

Valuation: Risky and Negative EBITDA

The valuation grade for Take Ltd is classified as risky, primarily due to its negative EBITDA of ₹-1.74 crores. Negative earnings before interest, taxes, depreciation, and amortisation highlight operational inefficiencies and cash flow challenges. Despite this, the stock price has shown some volatility, with a one-year return of +62.64% as of 12 September 2026, reflecting speculative interest or market anomalies rather than fundamental strength.

Profit growth over the past year has been robust at 80.4%, which might appear encouraging. However, the PEG ratio of 0.6 suggests that the stock is trading at a valuation that may not fully justify its earnings growth, especially given the underlying risks. Investors should be wary of valuations that do not align with sustainable profitability.

Financial Trend: Positive but Fragile

While the financial grade is positive, this must be interpreted with caution. The company’s recent profit growth contrasts with its operating losses and weak debt servicing capacity. The positive financial trend may be driven by short-term factors or accounting adjustments rather than a fundamental turnaround. Investors should monitor whether this trend can be sustained through improved operational efficiency and stronger cash flows.

Technical Outlook: Bearish Momentum

Technically, Take Ltd is rated bearish, indicating downward momentum in its stock price and potential resistance to upward movement. The stock’s recent performance shows mixed signals: a strong one-day gain of 4.96% and a one-week rise of 27.40% contrast sharply with declines over longer periods, including a 23.65% drop over one month and a 55.30% fall over six months. Year-to-date, the stock is down 55.33%, underscoring persistent selling pressure.

This bearish technical stance suggests that despite occasional rallies, the stock faces significant headwinds, and investors should exercise caution when considering entry points.

Stock Returns and Market Behaviour

As of 12 September 2026, Take Ltd’s stock returns present a complex picture. The stock has delivered a remarkable 62.64% return over the past year, which may attract speculative investors. However, shorter-term returns reveal volatility and weakness, with notable declines over the past three and six months. This inconsistency highlights the stock’s risk profile and the importance of aligning investment horizons with risk tolerance.

Summary for Investors

In summary, Take Ltd’s Strong Sell rating reflects a combination of below-average quality, risky valuation, a fragile but positive financial trend, and bearish technical indicators. Investors should interpret this rating as a cautionary signal, suggesting that the stock currently carries elevated risks that may not be offset by its recent gains or profit growth. Thorough due diligence and risk assessment are advised before considering any investment in this microcap healthcare services company.

This week's disclosed pick, a Large Cap from NBFC, comes with precise Target Price and analysis. Check if you're positioned right for this opportunity!

  • - Precise target price set
  • - Weekly selection live
  • - Position check opportunity

Check Your Position →

Contextualising Take Ltd’s Position in Healthcare Services

Operating within the healthcare services sector, Take Ltd’s microcap status adds an additional layer of risk due to limited market liquidity and higher volatility. The sector itself often demands strong operational execution and regulatory compliance, areas where the company’s below-average quality grade raises concerns. Investors typically favour healthcare firms with stable cash flows and robust fundamentals, which Take Ltd currently lacks.

Debt and Profitability Challenges

The company’s weak EBIT to interest ratio of -3.06 is a critical red flag, indicating that operating earnings are insufficient to cover interest expenses. This situation can lead to increased borrowing costs or refinancing risks, potentially exacerbating financial strain. Coupled with negative EBITDA, this suggests that Take Ltd is not generating adequate operational cash flow to sustain its business without external support or significant restructuring.

Valuation Risks Despite Profit Growth

Although profits have risen by 80.4% over the past year, the negative EBITDA and risky valuation grade imply that these gains may not be sustainable or reflective of core business strength. The PEG ratio of 0.6, while seemingly attractive, must be interpreted in the context of the company’s overall financial health and sector risks. Investors should be cautious about relying solely on profit growth without considering cash flow and balance sheet stability.

Technical Indicators and Market Sentiment

The bearish technical grade aligns with the stock’s recent price volatility and downward trends over medium-term periods. Despite short bursts of positive returns, the prevailing market sentiment appears cautious or negative. This technical outlook suggests that the stock may face resistance in recovering lost ground, and investors should be prepared for potential continued volatility.

Investor Takeaway

For investors, the Strong Sell rating serves as a clear indication to approach Take Ltd with caution. The combination of weak fundamentals, risky valuation, and bearish technical signals suggests that the stock is not currently a favourable investment. Those considering exposure should weigh the risks carefully and monitor the company’s operational improvements and financial health closely before committing capital.

Conclusion

Take Ltd’s current Strong Sell rating by MarketsMOJO, last updated on 02 July 2026, reflects a comprehensive evaluation of its present-day financial and market position as of 12 September 2026. While the company shows some positive profit trends, significant challenges in quality, valuation, and technical momentum underpin the cautious recommendation. Investors seeking stability and growth in the healthcare services sector may find more compelling opportunities elsewhere until Take Ltd demonstrates a clear turnaround in its fundamentals and market performance.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News